Apollomics Inc. balance sheet

At the end of fiscal 2025, Apollomics Inc. had total assets of $6.7m and shareholders' equity of −$3.2m. It held $3.3m in cash against $0 of debt: net cash of $3.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Apollomics Inc.: balance sheet, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	131	47	33	32	10	3
Total current assets	—	99	56	40	10	6
Total assets	—	123	76	55	13	7
Total current liabilities	—	14	12	14	7	6
Short-term debt	—	—	—	4	0	—
Total debt	0	0	0	4	0	0
Total liabilities	—	—	448	—	—	—
Shareholders' equity	−128	−213	−448	41	5	−3
Non-controlling interests and other (assets − liabilities − equity)	—	—	76	—	—	—
Net debt (negative = net cash)	−131	−47	−33	−28	−10	−3

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ACRS vs APLM APLM vs COYA ADAG vs APLM

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Apollomics Inc.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Apollomics Inc.